ENvue Medical Book Value Per Share Growth & History (FEED)
ENvue Medical's book value per share was $30.44 for fiscal 2025.
View full ENvue Medical company overviewENvue Medical annual book value per share history
| Fiscal year | Period ended | Book value per share | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $30.44 | $13.89 | +83.97% |
| 2024 | 2024-12-31 | $16.55 | -$197.88 | −92.28% |
| 2023 | 2023-12-31 | $214.43 | -$2.27 | −1.05% |
| 2022 | 2022-12-31 | $216.70 | -$279.36 | −56.32% |
| 2021 | 2021-12-31 | $496.06 | $248.17 | +100.11% |
| 2020 · Mar 31 | 2021-03-31 | $396.66 | — | — |
| 2020 · Dec 31 | 2020-12-31 | $247.89 | -$457.05 | −64.84% |
| 2019 | 2019-12-31 | $704.94 | $436.99 | +163.09% |
| 2018 | 2018-12-31 | $267.95 | -$1,763.32 | −86.81% |
| 2017 | 2017-12-31 | $2,031.27 | $4,119.54 | — |
| 2016 | 2016-12-31 | -$2,088.27 | -$1,912.19 | — |
| 2015 | 2015-12-31 | -$176.08 | $75,353.94 | — |
| 2014 | 2014-12-31 | -$75,530.02 | — | — |
ENvue Medical quarterly book value per share
| Fiscal quarter | Period ended | Book value per share | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $3.75 | -$47.04 | −92.61% |
| Q1 2026 | 2026-03-31 | $8.65 | -$477.37 | −98.22% |
| Q4 2025 | 2025-12-31 | $30.44 | $13.89 | +83.97% |
| Q3 2025 | 2025-09-30 | $42.00 | -$31.96 | −43.21% |
| Q2 2025 | 2025-06-30 | $50.79 | -$61.44 | −54.74% |
| Q1 2025 | 2025-03-31 | $486.02 | $347.59 | +251.09% |
| Q4 2024 | 2024-12-31 | $16.55 | -$197.88 | −92.28% |
| Q3 2024 | 2024-09-30 | $73.96 | -$206.07 | −73.59% |
| Q2 2024 | 2024-06-30 | $112.24 | $35.15 | +45.59% |
| Q1 2024 | 2024-03-31 | $138.43 | -$7.35 | −5.04% |
| Q4 2023 | 2023-12-31 | $214.43 | -$2.27 | −1.05% |
| Q3 2023 | 2023-09-30 | $280.03 | $32.19 | +12.99% |
| Q2 2023 | 2023-06-30 | $77.09 | -$247.75 | −76.27% |
| Q1 2023 | 2023-03-31 | $145.78 | -$267.62 | −64.74% |
| Q4 2022 | 2022-12-31 | $216.70 | -$279.36 | −56.32% |
| Q3 2022 | 2022-09-30 | $247.83 | -$457.30 | −64.85% |
| Q2 2022 | 2022-06-30 | $324.84 | -$55.12 | −14.51% |
| Q1 2022 | 2022-03-31 | $413.40 | $16.73 | +4.22% |
| Q4 2021 | 2021-12-31 | $496.06 | $248.17 | +100.11% |
| Q2 2021 | 2021-09-30 | $705.13 | $129.85 | +22.57% |
| Q1 2021 | 2021-06-30 | $379.96 | $779.80 | — |
| Q4 2020 · Mar 31 | 2021-03-31 | $396.66 | $142.69 | +56.18% |
| Q4 2020 · Dec 31 | 2020-12-31 | $247.89 | -$457.05 | −64.84% |
| Q3 2020 | 2020-09-30 | $575.28 | -$532.17 | −48.05% |
| Q2 2020 | 2020-06-30 | -$399.84 | -$1,428.11 | — |
| Q1 2020 | 2020-03-31 | $253.98 | $507.09 | — |
| Q4 2019 | 2019-12-31 | $704.94 | $436.99 | +163.09% |
| Q3 2019 | 2019-09-30 | $1,107.46 | $338.83 | +44.08% |
| Q2 2019 | 2019-06-30 | $1,028.27 | -$205.70 | −16.67% |
| Q1 2019 | 2019-03-31 | -$253.11 | -$1,904.28 | — |
| Q4 2018 | 2018-12-31 | $267.95 | -$1,763.32 | −86.81% |
| Q3 2018 | 2018-09-30 | $768.63 | $4,352.69 | — |
| Q2 2018 | 2018-06-30 | $1,233.97 | $3,783.51 | — |
| Q1 2018 | 2018-03-31 | $1,651.17 | $3,993.48 | — |
| Q4 2017 | 2017-12-31 | $2,031.27 | $4,119.54 | — |
| Q3 2017 | 2017-09-30 | -$3,584.06 | -$2,244.53 | — |
| Q2 2017 | 2017-06-30 | -$2,549.54 | -$1,576.87 | — |
| Q1 2017 | 2017-03-31 | -$2,342.30 | -$1,834.17 | — |
| Q4 2016 | 2016-12-31 | -$2,088.27 | -$1,912.19 | — |
| Q3 2016 | 2016-09-30 | -$1,339.53 | -$1,764.99 | — |
| Q2 2016 | 2016-06-30 | -$972.67 | -$2,212.80 | — |
| Q1 2016 | 2016-03-31 | -$508.14 | -$1,833.06 | — |
| Q4 2015 | 2015-12-31 | -$176.08 | $75,353.94 | — |
| Q3 2015 | 2015-09-30 | $425.45 | — | — |
| Q2 2015 | 2015-06-30 | $1,240.14 | — | — |
| Q1 2015 | 2015-03-31 | $1,324.93 | — | — |
| Q4 2014 | 2014-12-31 | -$75,530.02 | — | — |
ENvue Medical book value per share trends
Over the last five fiscal years, ENvue Medical's book value per share decreased from $247.89 to $30.44, a change of -$217.45. The latest reported quarter, Q2 2026, shows $3.75.
What book value per share means
Book value per share estimates the common shareholders’ accounting equity represented by each share. It can help compare a company’s balance-sheet value over time, although market value can differ substantially from book value.
How book value per share is calculated
TickerStat calculates book value per share as SEC-reported common shareholders’ equity divided by reported period-end common shares. Preferred equity is subtracted when separately reported, and basic weighted-average shares are used only when period-end shares are unavailable. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review ENvue Medical source filings ↗